Ludwig Enterprises, Inc. (LUDG)
OTCMKTS · Delayed Price · Currency is USD
0.0700
0.00 (0.00%)
Jan 20, 2026, 10:57 AM EST
Ludwig Enterprises Market Cap
Ludwig Enterprises has a market cap or net worth of $11.38 million as of January 20, 2026. Its market cap has decreased by -64.92% in one year.
Market Cap
11.38M
Enterprise Value
13.38M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since April 8, 2008, Ludwig Enterprises's market cap has increased from 9.52M to 11.38M, an increase of 19.54%. That is a compound annual growth rate of 1.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 11.38M | 34.62% |
| Dec 31, 2025 | 8.45M | -64.15% |
| Dec 31, 2024 | 23.58M | 11.95% |
| Dec 29, 2023 | 21.07M | -75.70% |
| Dec 30, 2022 | 86.68M | 1,885.39% |
| Dec 31, 2021 | 4.37M | -38.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |